Imperial Prostate
@IP_London
A collective of expert urologists, medical specialists, and experienced researchers working to change the way the world diagnoses and treats prostate disease
Thank you for engaging with us this year at the first joint #IPFTSmasterclass - see you in London in 2026! @FocalSociety
Wrapping up the session is @Reddy4Urology with the outcomes of 1379 men undergoing #FocalTherapy with #HIFU 🦾
Great to see one of our Chairs of Urology @Heer_Lab on the cover of the latest Urology Matters @TUF_tweets! Discussions about #TRANSFORM, his research programme at @imperialcollege and role as Chair of the Scientific and Education Committee at @TUF_tweets
🚨 SAVE THE DATE: 12th December 2025 📍 Hammersmith, London The Imperial Experimental Cancer Medicine Centre (ECMC) is hosting a one-day masterclass designed for early-career researchers in surgery and interventional sciences 🔗 Register now! tickettailor.com/events/imperia…
The protocol paper for the #IP7PACIFIC RCT is now available online! This trial led by our group and funded by @CR_UK will provide definitive evidence for "fast" biparametric MRI and image-fusion biopsy using a novel trial design 🚨 @NikhilMayor sciencedirect.com/science/articl…
Great news! The IP7-PACIFIC Protocol paper has been published 😍 take a look... 👀 sciencedirect.com/science/articl… @IP_London @jonathananing @bui_nbt @ResearchNBT @rjcousins4 @MartaCobos1984
Great to see our PhD student @NikhilMayor present the #TRANSFORM trial at tonight’s @Uroweb UROwebinar: The role of MRI in prostate cancer screening and diagnosis Recruitment to start later this year! @LondonProstate1 @ProstateUK
Congratulations to the #IP2ATLANTA trials team on their presentation being selected for best of #BAUS25 @LondonProstate1 @Connor_Urol
Finishing up #BAUS25 on the main stage our Clinical Lecturer @Connor_Urol presenting an update on two major UK prostate randomised controlled trial published this year #TRANSLATE #NEUROSAFE
[4/8] 🦆The TRANSFORM team @NikhilMayor @Fran_Rawlins @AJWLight @philipmcnamee @IP_London @QMULSocialPsych helped supporters of all ages understand how we’re working to find the best way to screen men for #ProstateCancer. 🔗prostatecanceruk.org/research/trans…
Meanwhile! Back at in London, @Fran_Rawlins gave a brilliant presentation showcasing TRANSFORM at the @ImperialCTU Unit Meeting 2025 #prostatecancer #prostatescreening @ImperialSandC @ProstateUK @LondonProstate1
Fantastic overview of diagnostic and therapeutic strategies in radiorecurrent prostate cancer by @TaimurShah Key takeaways - MRI highly sensitive for local disease (even more so with PSMA PET/CT) & focal therapy as effective as RP in the salvage setting #BAUS25
Brilliant prostate cancer abstract session this morning with 4️⃣ presentations from Team IP at #BAUS25 Huge breadth covered including MRI diagnostics, focal therapy, intraoperative margin assessment, and cytoreduction strategies in metastatic disease
Next up @cut_tt_chase presents the 5 year oncological outcomes of men with initial negative #ProstateCancer investigations in the #RAPID pathway 🏃
It’s a busy #ProstateCancer session at #BAUS25 - kicking off is @Connor_Urol with the outcomes from the #IP2ATLANTA pilot study 📊
Fantastic to see our FY1 Karen Gao present our data on Rezum for prostates >80mL. Take home - durable results with good patient satisfaction @lyanleung #BAUS25
Powerful opening from @LondonProstate1 to the #BAUS25 plenary session We have insufficient capacity and data to endorse screening in 2025. New evidence is critically needed first Watch this space for the £42M #TRANSFORM screening trial - Phase 1 will start later this year
#IP2ATLANTA pilot published @EUplatinum 🔬 9 in 10 patients have a viable prostate tumour despite ADT+ARTA/Doce 🚦Early signal in prostate cancer mortality for cytoreductive arms 📈 Surgery, radiotherapy, ablation + SABR safe -> n=433 PFS exp.2027! euoncology.europeanurology.com/article/S2588-…
A big welcome to @DaUroKing & the @GlanClwydHospital team — first Welsh site to join #IP9ATLAS ! Excited to work together on this trial for our #ProstateCancer #ActiveSurveillance patients
It's a real honour to be awarded the Alavi-Mandell Award by @SNM_MI for our work published in @JournalofNucMed on 68Ga-PSMA-11 PET/CT in detecting intra-prostatic radiorecurrent prostate cancer 👇 jnm.snmjournals.org/content/early/… Thanks to Tara Barwick @TaimurShah @LondonProstate1!
🎥@NikhilMayor of @IP_London outlines the IP7-PACIFIC trial at #EAU25, comparing bpMRI vs mpMRI & biopsy methods in prostate cancer. Results aim to refine imaging guidelines. 🎯 ➡️ow.ly/caRr50VBGhW⬅️ #PCSM #UroOnc #UroSoMe